The Pneumonia Vaccine (PCV13, Prevnar 13®) protects against 13 strains of pneumococcal bacteria that cause pneumonia, meningitis, and bloodstream infections. It is especially important for young children, adults 65 and older, and anyone with chronic health conditions.
Key things to know about the vaccine and how it works.
Covers 13 different strains, providing broad and reliable protection against common pneumococcal bacteria.
This extensive coverage is key to preventing respiratory-related hospitalizations and complications.
Safe and well-tolerated, with mild side effects like arm soreness or low-grade fever.
Targeted toward those with the highest risks for pneumococcal infections, including children, seniors, and people with underlying health concerns.
Who should receive the PCV13 vaccine? When should you get vaccinated?
The Pneumonia Vaccine (PCV13) protects against 13 strains of pneumococcal bacteria, reducing the risk of serious infections like pneumonia, meningitis, and sepsis for long-term health benefits.
Significantly lowers the chances of developing serious forms of pneumonia and its complications, such as sepsis or respiratory failure.
Minimizes hospitalizations, ER visits, and doctor appointments, leading to fewer disruptions in daily life and less strain on healthcare systems.
Widespread vaccination reduces overall transmission, protecting those unable to get vaccinated and supporting community health.
Reduces the worry of frequent respiratory infections and promotes a more active, worry-free lifestyle, especially for older adults.
Reduces costs associated with medical treatment for pneumonia, including lost wages, transportation, and prescription medications.
Answers to what patients ask most often about this vaccine.
PCV13 (Prevnar 13®) is a vaccine that protects against 13 types of pneumococcal bacteria that can cause serious infections like pneumonia, meningitis, and bloodstream infections
All children under 2 years old Adults 65 years or older (discuss with healthcare provider) People 2-64 years with certain medical conditions that increase risk Immunocompromised individuals
For children: 2 months: First dose 4 months: Second dose 6 months: Third dose 12-15 months: Fourth dose (booster) For adults 65+: Single dose May need additional pneumococcal vaccines (PPSV23) based on provider recommendation
Injection site reactions: redness, swelling, pain Mild fever Irritability in children Fatigue Headache Muscle aches Reduced appetite (in children)
Severe allergic reactions are rare but possible. Seek immediate medical attention if experiencing: Difficulty breathing Rapid heartbeat Dizziness High fever Severe skin rash
Seek immediate medical attention if experiencing: 1. Anyone with severe allergic reaction to previous dose 2. Individuals allergic to any vaccine components 3. Those with severe illness (mild illnesses are okay)
Yes, PCV13 can be administered with other vaccines during the same visit at different injection sites
Most insurance plans cover PCV13. Medicare Part B covers pneumococcal vaccines for adults 65+. Check with your provider for specific coverage details
Protection is long-lasting. Most people don't need additional doses beyond the recommended schedule unless they have specific medical conditions
Primary care physician offices Pediatrician offices Pharmacies Local health departments Travel clinics
Healthcare providers must store PCV13 in a refrigerator between 36°F and 46°F (2°C to 8°C). Do not freeze. Find answers to your questions about the PCV13 vaccine, including who should receive it and what it protects against. All children under 2 years old Adults 65 years or older (discuss with healthcare provider) People 2-64 years with certain medical conditions that increase risk Immunocompromised individuals
Walk in or book ahead at any of our 15 SureVax branches across Metro Manila. Open daily 7 AM–9 PM.

Shingles, a painful viral infection, poses a significant risk to adults over 50. Caused by the reactivation of the varicella-zo…
Read More →
Shingles, also known as herpes zoster, is a painful viral infection caused by the reactivation of the varicella-zoster virus, t…
Read More →